Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-Versus-Host Disease in Reduced Intensity Conditioning Double Umbilical Cord Blood Transplantation

Mycophenolate mofetil (MMF) is frequently used in hematopoietic cell transplantation (HCT) for graft-versus-host disease (GVHD) prophylaxis and to facilitate engraftment. We previously reported that a higher level of mycophenolic acid can be achieved with an MMF dose of 3 g/day as compared to 2g/day...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Bejanyan, Nelli, Rogosheske, John, DeFor, Todd, Lazaryan, Aleksandr, Esbaum, Kelli, Holtan, Shernan, Arora, Mukta, MacMillan, Margaret L., Weisdorf, Daniel, Jacobson, Pamala, Wagner, John, Brunstein, Claudio G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768800/
https://ncbi.nlm.nih.gov/pubmed/25655791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.01.023
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi